Inventor
KATO DARRYL
US46 patents
⚠️ This page may combine multiple inventors who share the name “KATO DARRYL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
30 patentsUS8575135B2Nov 5, 2013
Antiviral compounds
GILEAD SCIENCES INC42 citations98
US10294234B2May 21, 2019
HIV inhibitor compounds
GILEAD SCIENCES INC43 citations97
US8940718B2Jan 27, 2015
Antiviral compounds
GILEAD SCIENCES INC26 citations96
US11078208B1Aug 3, 2021
HIV inhibitor compounds
GILEAD SCIENCES INC13 citations94
US9873680B2Jan 23, 2018
Therapeutic compounds
GILEAD SCIENCES INC26 citations94
US11787825B2Oct 17, 2023
Therapeutic compounds for HIV virus infection
GILEAD SCIENCES INC14 citations93
US10703733B2Jul 7, 2020
MCL-1 inhibitors
GILEAD SCIENCES INC12 citations93
US9296782B2Mar 29, 2016
Inhibitors of hepatitis C virus
GILEAD SCIENCES INC13 citations92
US8841278B2Sep 23, 2014
Antiviral compounds
GILEAD SCIENCES INC20 citations92
US8822430B2Sep 2, 2014
Antiviral compounds
GILEAD SCIENCES INC17 citations92
US11680064B2Jun 20, 2023
Capsid inhibitors for the treatment of HIV
GILEAD SCIENCES INC9 citations86
US10988451B2Apr 27, 2021
MCL-1 inhibitors
GILEAD SCIENCES INC10 citations85
US10752636B2Aug 25, 2020
HIV inhibitor compounds
GILEAD SCIENCES INC7 citations84
US12084467B2Sep 10, 2024
Therapeutic compounds for HIV virus infection
GILEAD SCIENCES INC7 citations83
US9376441B2Jun 28, 2016
Substituted pyrrolidines as SYK inhibitors
GILEAD SCIENCES INC17 citations82
US11643400B2May 9, 2023
MCL-1 inhibitors
GILEAD SCIENCES INC4 citations74
US12084455B2Sep 10, 2024
HIV inhibitor compounds
GILEAD SCIENCES INC2 citations73
US10442804B2Oct 15, 2019
Compounds for the treatment of hepatitis B virus infection
GILEAD SCIENCES INC4 citations73
US11667652B2Jun 6, 2023
MCL1 inhibitors
GILEAD SCIENCES INC2 citations72
US10005774B2Jun 26, 2018
Syk inhibitors
GILEAD SCIENCES INC4 citations72
US9655944B2May 23, 2017
Inhibitors of hepatitis C virus
GILEAD SCIENCES INC2 citations72
US12404262B2Sep 2, 2025
Therapeutic compounds for HIV virus infection
GILEAD SCIENCES INC1 citations63
US12479853B2Nov 25, 2025
HIV inhibitor compounds
GILEAD SCIENCES INC0 citations62
US12202842B2Jan 21, 2025
MCL1 inhibitors
GILEAD SCIENCES INC0 citations62
US12162844B2Dec 10, 2024
MCL-1 inhibitors
GILEAD SCIENCES INC0 citations62
US11052087B2Jul 6, 2021
Anti-HIV compounds
GILEAD SCIENCES INC1 citations62
US12187753B2Jan 7, 2025
Therapeutics compounds for HIV virus infection
GILEAD SCIENCES INC0 citations61
US12448400B2Oct 21, 2025
KRAS G12D modulating compounds
GILEAD SCIENCES INC0 citations56
US10030033B2Jul 24, 2018
Synthesis of an antiviral compound
GILEAD SCIENCES INC0 citations47
US9440991B2Sep 13, 2016
Synthesis of an antiviral compound
GILEAD SCIENCES INC1 citations47
GILEAD PHARMASSET LLC
11 patentsUS8921341B2Dec 30, 2014
Antiviral compounds
GILEAD PHARMASSET LLC31 citations96
US9868745B2Jan 16, 2018
Antiviral compounds
GILEAD PHARMASSET LLC8 citations92
US9221833B2Dec 29, 2015
Antiviral compounds
GILEAD PHARMASSET LLC20 citations92
US9051340B2Jun 9, 2015
Antiviral compounds
GILEAD PHARMASSET LLC20 citations92
US9511056B2Dec 6, 2016
Antiviral compounds
GILEAD PHARMASSET LLC7 citations84
US10807990B2Oct 20, 2020
Antiviral compounds
GILEAD PHARMASSET LLC1 citations73
US9981955B2May 29, 2018
Antiviral compounds
GILEAD PHARMASSET LLC2 citations73
US9809600B2Nov 7, 2017
Antiviral compounds
GILEAD PHARMASSET LLC2 citations73
US10335409B2Jul 2, 2019
Inhibitors of hepatitis C virus
GILEAD PHARMASSET LLC1 citations72
US10344019B2Jul 9, 2019
Antiviral compounds
GILEAD PHARMASSET LLC0 citations52
US10603318B2Mar 31, 2020
Inhibitors of hepatitis C virus
GILEAD PHARMASSET LLC0 citations50